Speaker
John Cleland
University of Glasgow,
Glasgow
(United Kingdom of Great Britain & Northern Ireland )
Speciality :
Chronic Heart Failure
76 presentations
Professor Cleland is a Cardiologist and Director of the Robertson Centre for Biostatistics (Glasgow), an internationally renowned Clinical Trials Unit offering a complete service both to academia and industry for cardiovascular and metabolic disease.
His main interest is heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. Particular current interests include myocardial substrate, congestion & inflammation, telemonitoring & theranostics.
He qualified from the University of Glasgow in 1977, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation. He was appointed Prof. at the University of Hull and, in 2013, the National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College London.
He founded the European Journal of Heart Failure. He is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure
76
presentations
from this speaker
Congestion monitoring.
Event :
Heart Failure 2019
Session :
Parade of devices 1: attend and learn
Speaker : J
Cleland
(Glasgow,GB)
Omecaptiv.
Event :
Heart Failure 2019
Session :
Emerging therapies in heart failure
Speaker : J
Cleland
(Glasgow,GB)
Joint Session with the working group on pharmacotherapy of the ESC
Potassium and heart failure.
Event :
Webinar 2019
Session :
HFA Webinars 2019
Speaker : S
Anker
(Berlin,DE), J
Cleland
(Glasgow,GB), M
Lainscak
(Murska Sobota,SI), F
Zannad
(Vandoeuvre,FR)
Devices
Event :
Heart Failure 2018
Session :
The year's best papers on heart failure
Speaker : J
Cleland
(Glasgow,GB)
Panel Q&A / Discussion.
Event :
Heart Failure 2017
Session :
New opportunities for an old problem: lowering potassium to maximize heart failure therapy
Speaker : F
Zannad
(Vandoeuvre,FR), J
Cleland
(Glasgow,GB), P
Van Der Meer
(Groningen,NL)
Organised by Lorraine University, supported by an unrestricted educational grant from AstraZeneca
The path to leadless CRT.
Event :
ESC Congress 2017
Session :
The future therapy of heart failure: shall we find the answers in the crystal ball?
Speaker : J
Cleland
(Glasgow,GB)
For whom is CRT best suited - A debate with myself.
Event :
Heart Failure 2016
Session :
New developments and controversial issues in heart failure
Speaker : J
Cleland
(Glasgow,GB)
Joint session with the Heart failure Association of India and the CSI-Heart Failure Council
ICD and CRT.
Event :
Heart Failure 2016
Session :
The new ESC Guidelines: Focus on arrhythmias and devices
Speaker : J
Cleland
(Glasgow,GB)
Indications.
Event :
Heart Failure 2016
Session :
ICD therapy in heart failure
Speaker : J
Cleland
(Glasgow,GB)
Introduction.
Event :
Heart Failure 2016
Session :
Latest developments in cardiac resynchronisation therapy
Speaker : J
Cleland
(Glasgow,GB)
Oral anticoagulants today.
Event :
Heart Failure 2016
Session :
Oral anticoagulation in patients with heart failure: today and tomorrow
Speaker : J
Cleland
(Glasgow,GB)
QRS width and bundle branch morphology.
Event :
Heart Failure 2016
Session :
Controversies in cardiac re-synchronisation therapy
Speaker : J
Cleland
(Glasgow,GB)
Joint Session with the European Heart Rhythm Association (EHRA)
Cardiac myosin activators.
Event :
Heart Failure 2015
Session :
Acute heart failure: novel therapies on the horizon
Speaker : J
Cleland
(Glasgow,GB)
Clinical development concepts moving forward.
Event :
Heart Failure 2015
Session :
Mitochondria in heart failure: a new target for therapy and recent first results
Speaker : J
Cleland
(Glasgow,GB)
Sponsored by Charité University Berlin and Stealth Peptides
CRT and ICD.
Event :
ESC Congress 2015
Session :
Devices for heart failure today
Speaker : J
Cleland
(Glasgow,GB)
Non-LBBB with QRS >150 ms.
Event :
EHRA 2015
Session :
Cardiac resynchronisation therapy (CRT) in heart failure: indication or not?
Speaker : J
Cleland
(Glasgow,GB)
MORE-CRT: Discussant review
Event :
ESC Congress 2014
Session :
Hot Line: Cardiovascular disease: novel therapies
Speaker : J
Cleland
(Glasgow,GB)
Telehealth - good value for money?
Event :
ESC Congress 2014
Session :
Technology and the Internet: innovative ways to provide cardiovascular disease prevention
Speaker : J
Cleland
(Glasgow,GB)
New drugs.
Event :
ESC Congress 2013
Session :
Treating acute and advanced heart failure: what clinicians need to know in 2013
Speaker : J
Cleland
(Glasgow,GB)
New kids.
Event :
ESC Congress 2013
Session :
Antithrombotics in heart failure
Speaker : J
Cleland
(Glasgow,GB)
